Cargando…

Pru p 3 oral immunotherapy efficacy, induced immunological changes and quality of life improvement in patients with LTP syndrome

Detalles Bibliográficos
Autores principales:	González Pérez, Alejandra, Carbonell Martínez, Antonio, Escudero Pastor, Ana Isabel, Navarro Garrido, Cristina, Miralles López, Juan Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7278159/ https://www.ncbi.nlm.nih.gov/pubmed/32523680 http://dx.doi.org/10.1186/s13601-020-00325-y

Ejemplares similares

Frequency of LTP (Pru p 3) and Profilin (Pru p 4) sensitisation in 1052 patients referenced to an immunoallergology department in Lisbon
por: Pereira Santos, M Conceição, et al.
Publicado: (2014)

Frequency of LTP (Pru p 3) and profilin (Pru p 4) sensitization in 1052 patients referenced to an Imunoallergology Department in Lisbon
por: Silva, PM, et al.
Publicado: (2013)

Specific sublingual immunotherapy with peach LTP (Pru p 3). One year treatment: a case report
por: Pereira, Celso, et al.
Publicado: (2009)

Combined LTP Sublingual and Oral Immunotherapy in LTP Syndrome: Efficacy and Safety
por: Martin Iglesias, Maria Aranzazu, et al.
Publicado: (2023)

LTP cross-reactivity - primary sensitization to mugwort pollen LTP Art v 3, facilitates subsequent sensitisation to peach LTP Pru p 3 in mice
por: Wangorsch, Andrea, et al.
Publicado: (2014)

Immunological changes after one year of specific immunotherapy with Pru p 3
por: Gomez, Francisca, et al.
Publicado: (2015)

Evaluation of peach tolerance after one year of sublingual immunotherapy with LTP (Pru p 3) in allergic patients sensitises to food by LTPs
por: Bagos, Gador, et al.
Publicado: (2015)

Allergenic Characterization of New Mutant Forms of Pru p 3 as New Immunotherapy Vaccines
por: Gómez-Casado, C., et al.
Publicado: (2013)

Poster 1020: Efficacy and safety of sublingual specific immunotherapy with Pru p 3 in a portuguese population - clinical and immunological evaluation during 12 months
por: Costa, Ana Célia, et al.
Publicado: (2014)

A description of the PRU device
por: McCormick, B H
Publicado: (1962)

Subjects develop tolerance to Pru p 3 but respiratory allergy to Pru p 9: A large study group from a peach exposed population
por: Somoza, Maria Luisa, et al.
Publicado: (2021)

Hypoallergenic allergen derivatives of Pru p 3 for immunotherapy of IgE-mediated peach allergy
por: Linhart, B, et al.
Publicado: (2013)

Tomato hypersensitivity in peach allergic patients: rPru p3 and rPru p1 positivity is predictive of the symptom severity
por: Piantanida, Marta, et al.
Publicado: (2011)

Saclay : Mûre est la pru(g)ne
Publicado: (1970)

Basophils response to Pru p 3 and Ara h 9 in patients sensitised to peach under specific immunotherapy
por: Gomez, Francisca, et al.
Publicado: (2014)

Immunotherapy with Pru p 3 for food allergy to peach and non-specific lipid transfer protein: a systematic review
por: Rossi, Carlo Maria, et al.
Publicado: (2023)

Pru p 3 sensitization in children with allergy to Parietaria pollens
por: Giorgio, Ciprandi, et al.
Publicado: (2019)

Structure and Zeatin Binding of the Peach Allergen Pru p 1
por: Eidelpes, Reiner, et al.
Publicado: (2021)

Pru p 9, a new allergen eliciting respiratory symptoms in subjects sensitized to peach tree pollen
por: Blanca, Miguel, et al.
Publicado: (2020)

Severe peach allergy in patients non-sensitized to Pru p 3
por: Leoni, MC, et al.
Publicado: (2013)

The impact of age on Pru p 3 IgE production in Italy
por: Ciprandi, Giorgio, et al.
Publicado: (2017)

PutA Is Required for Virulence and Regulated by PruR in Pseudomonas aeruginosa
por: Zheng, Ruiping, et al.
Publicado: (2018)

Immunotherapy with Native Molecule rather than Hypoallergenic Variant of Pru p 3, the Major Peach Allergen, Shows Beneficial Effects in Mice
por: Rodriguez, Maria J., et al.
Publicado: (2018)

Rational Design, Structure–Activity Relationship, and Immunogenicity of Hypoallergenic Pru p 3 Variants
por: Eichhorn, Stephanie, et al.
Publicado: (2019)

Innate lymphoid cells type 2 in LTP‐allergic patients and their modulation during sublingual immunotherapy
por: Palomares, Francisca, et al.
Publicado: (2021)

Correction: Pru p 9, a new allergen eliciting respiratory symptoms in subjects sensitized to peach tree pollen
por: Blanca, Miguel, et al.
Publicado: (2020)

The Ubiquitin E3 Ligase PRU2 Modulates Phosphate Uptake in Arabidopsis
por: Sun, Mi-Mi, et al.
Publicado: (2022)

Identification of Pru du 6 as a potential marker allergen for almond allergy
por: Kabasser, Stefan, et al.
Publicado: (2020)

Energy Landscapes of Ligand Motion Inside the Tunnel-Like Cavity of Lipid Transfer Proteins: The Case of the Pru p 3 Allergen
por: Cuevas-Zuviría, Bruno, et al.
Publicado: (2019)

Skin Testing With Peach Peel Extract Versus Serum IgE to Pru p 3 as a Stronger Predictor of Peach-Induced Anaphylaxis
por: Somoza, Maria Luisa, et al.
Publicado: (2021)

Gibberellin‐regulated protein in Japanese apricot is an allergen cross‐reactive to Pru p 7
por: Inomata, Naoko, et al.
Publicado: (2017)

NMR resonance assignments of the pathogenesis-related peach allergen Pru p 1.0101
por: Führer, Sebastian, et al.
Publicado: (2018)

Introduction of protocols for mass production of Toxoplasma gondii tachyzoites of the genotype II PRU strain
por: Bahreini, Mohammad Saleh, et al.
Publicado: (2021)

Isolation and Functional Analysis of ZmLTP3, a Homologue to Arabidopsis LTP3
por: Zou, Hua-Wen, et al.
Publicado: (2013)

Glycosylated nanostructures in sublingual immunotherapy induce long-lasting tolerance in LTP allergy mouse model
por: Rodriguez, Maria J., et al.
Publicado: (2019)

Understanding LTP in pain pathways
por: Sandkühler, Jürgen
Publicado: (2007)

LTP in a Culture Dish
por: MacDonald, J.F., et al.
Publicado: (2001)

Prevalence and clinical relevance of low levels of Pru p 3 specific IgE in patients with peach sensitization
por: Pascal, M, et al.
Publicado: (2013)

Development of a hypoallergenic and immunogenic Pru p 3 proline variant for treatment of peach allergy
por: Eichhorn, Stephanie, et al.
Publicado: (2014)

Platelet reactivity unit (PRU) in patients undergoing elective PCI: Rethinking the optimal cut point
por: Sharifi, Hassan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_glt10pvlrc8cd5r0choenbgnko